MYH14 and ocular melanoma: Understanding the complex mechanism of action of OM on cardiac sarcomeres in relation to regional gene expression patterns and metabolic conditions may also help explain disappointing results in clinical trials and inform future drug development strategies for the treatment of HFrEF based on small molecules acting as myosin modulators.